High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study.
作者:
主题词
成年人(Adult);老年人(Aged);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);女(雌)性(Female);人类(Humans);异环磷酰胺(Ifosfamide);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);泼尼松(Prednisone);复发(Recurrence);干细胞移植(Stem Cell Transplantation);存活率分析(Survival Analysis);长春碱(Vinblastine)
DOI
10.1111/bjh.12379
PMID
23692641
发布时间
2018-12-03
- 浏览64
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文